What Wall Street Analysts Are Buzzing About This Morning

Trader Wall Street Screen Bloomberg Terminal

Photo: Justin Sullivan/Getty Images

Good morning. Here’s your daily equity research round up from the Street.Morgan Stanley: 

Kinder Morgan Inc. (KMI): Morgan Stanley has upgraded Kinder Morgan shares from neutral to overweight. Morgan Stanley likes the pipeline company’s solid growth and thinks that the shares are attractively valued, trading at $35.05 pre-market. 

Jefferies:

Target (TGT): Analyst Daniel Binder has raised his price target for the retailer from $67 to $74. They saw quite a bit they liked from Target’s earnings announcement, with upside in EPS and revenue in line. The third quarter is looking positive as well, with early trends indicating same store sales will continue to increase.

Bank of America: 

Genomic Health (GHDX): Bank of America has initiated coverage of the genomics company with a $44 price target. The company is a leader in the development of diagnostic genetic tests for cancer, essential for the growing field of personalised medicine, and it already has a successful breast cancer diagnostic. They expect upcoming results from a diagnostic for prostate cancer to be positive. 

Don’t miss: Credit Suisse — These 7 Stocks Will Rise With The Machines >

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.

Tagged In

moneygame-us